Tutorials
NAS:ADAG (China)  
Adagene Inc logo

Adagene Inc

$ 1.41 -0.05 (-3.42%) 08:08 PM EST
P/E:
At Loss
P/B:
0.40
Market Cap:
$ 61.75M
Enterprise V:
$ -102.96M
Volume:
206.63K
Avg Vol (2M):
106.54K
Also Trade In:
Volume:
206.63K
Market Cap $:
61.75M
PE Ratio:
At Loss
Avg Vol (2-Month):
106.54K
Enterprise Value $:
-102.96M
PB Ratio:
0.40
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Adagene Inc
Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123
Description
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
Name Current Vs Industry Vs History
Cash-To-Debt 23.28
Equity-to-Asset 0.83
Debt-to-Equity 0.05
Debt-to-EBITDA -0.32
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.42
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 23.78
9-Day RSI 22.66
14-Day RSI 22.72
6-1 Month Momentum % -71.86
12-1 Month Momentum % -88.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.24
Quick Ratio 6.24
Cash Ratio 5.85
Days Sales Outstanding 1689.18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.3

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -6090.28
Net Margin % -6192.33
ROE % -28.81
ROA % -14.77
ROIC % -161.71
ROC (Joel Greenblatt) % -883.98
ROCE % -17.31

Financials (Next Earnings Date:2022-08-26 Est.)

ADAG's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ADAG

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.391
EPS (TTM) ($) -1.825
Beta 0
Volatility % 45.12
14-Day RSI 22.72
14-Day ATR ($) 0.123949
20-Day SMA ($) 1.652935
12-1 Month Momentum % -88.21
52-Week Range ($) 1.38 - 18.975
Shares Outstanding (Mil) 43.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Adagene Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More